MetaADEDB 2.0 @ LMMD
Chloraprep One-step
(NVLOJMREADOIJY-ZHOPZBLYSA-N)
Structure
SMILES
NC(=NCCCCCCN=C(/N=C(/Nc1ccc(cc1)Cl)\N)N)/N=C(/Nc1ccc(cc1)Cl)\N.CC(O)C.OC[C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O.OC[C@H]([C@H]([C@@H](CC(=O)O)O)O)O
Molecular Formula:
C37H62Cl2N10O14
Molecular Weight:
941.853
Log P:
0.7139
Hydrogen Bond Acceptor:
24
Hydrogen Bond Donor:
18
TPSA:
454.48
CAS Number(s):
74194-72-2
Synonym(s)
1.
Chloraprep One-step
External Link(s)
PubChem Compound44144774
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Application site reactionFAERS: 203US FAERS
2Application site rashFAERS: 156US FAERS
3Application site erythemaFAERS: 84US FAERS
4Application site pruritusFAERS: 73US FAERS
5LacerationFAERS: 66US FAERS
6Occupational exposure to productFAERS: 47US FAERS
7Skin irritationFAERS: 42US FAERS
8Application site vesiclesFAERS: 34US FAERS
9Application site irritationFAERS: 29US FAERS
10Application site papulesFAERS: 29US FAERS
11UrticariaFAERS: 28US FAERS
12Product package associated injuryFAERS: 22US FAERS
13Application site burnFAERS: 17US FAERS
14Thermal burnFAERS: 16US FAERS
15Accidental exposure to productFAERS: 14US FAERS
16No adverse eventFAERS: 12US FAERS
17Application site painFAERS: 11US FAERS
18Product quality issueFAERS: 11US FAERS
19Application site hypersensitivityFAERS: 10US FAERS
20Device related infectionFAERS: 10US FAERS
21ErythemaFAERS: 10US FAERS
22HypersensitivityFAERS: 10US FAERS
23Procedural complicationFAERS: 10US FAERS
24PruritusFAERS: 10US FAERS
25Chemical burn of skinFAERS: 9US FAERS
26skin abrasionFAERS: 9US FAERS
27Caustic injuryFAERS: 8US FAERS
28Eye painFAERS: 7US FAERS
29Product contaminationFAERS: 6US FAERS
30Rash erythematousFAERS: 6US FAERS
31Application site dischargeFAERS: 5US FAERS
32Application site urticariaFAERS: 5US FAERS
33Injury associated with deviceFAERS: 5US FAERS
34Post procedural infectionFAERS: 5US FAERS
35Skin reactionFAERS: 5US FAERS
36Application site scarFAERS: 4US FAERS
37Exposure via direct contactFAERS: 4US FAERS
38Product container issueFAERS: 4US FAERS
39Application site exfoliationFAERS: 3US FAERS
40Bacterial test positiveFAERS: 3US FAERS
41Burning sensationFAERS: 3US FAERS
42Chemical injuryFAERS: 3US FAERS
43Eye irritationFAERS: 3US FAERS
44Pharmaceutical product complaintFAERS: 3US FAERS
45Post procedural complicationFAERS: 3US FAERS
46Wrong technique in product usage processFAERS: 3US FAERS
47Application site erosionFAERS: 2US FAERS
48Application site lacerationFAERS: 2US FAERS
49Application site swellingFAERS: 2US FAERS
50Chest discomfortFAERS: 2US FAERS
51DermatitisFAERS: 2US FAERS
52Device FailureFAERS: 2US FAERS
53DizzinessFAERS: 2US FAERS
54Drug administered at inappropriate siteFAERS: 2US FAERS
55Drug administration errorFAERS: 2US FAERS
56EscharFAERS: 2US FAERS
57Iatrogenic injuryFAERS: 2US FAERS
58InflammationFAERS: 2US FAERS
59Lip swellingFAERS: 2US FAERS
60Medication ErrorFAERS: 2US FAERS
61PetechiaeFAERS: 2US FAERS
62Product contamination physicalFAERS: 2US FAERS
63Secretion dischargeFAERS: 2US FAERS
64SepsisFAERS: 2US FAERS
65SneezingFAERS: 2US FAERS
66SwellingFAERS: 2US FAERS
67Unevaluable eventFAERS: 2US FAERS
68Wrong technique in drug usage processFAERS: 2US FAERS
69Accidental exposureFAERS: 1US FAERS
70AnxietyFAERS: 1US FAERS
71Application site cellulitisFAERS: 1US FAERS
72Application site drynessFAERS: 1US FAERS
73Application site infectionFAERS: 1US FAERS
74Application site inflammationFAERS: 1US FAERS
75Application site massFAERS: 1US FAERS
76Application site pustulesFAERS: 1US FAERS
77Application site scabFAERS: 1US FAERS
78Arteriovenous fistula site infectionFAERS: 1US FAERS
79Cardiac function disturbance postoperativeFAERS: 1US FAERS
80CataractFAERS: 1US FAERS
81Catheter site erythemaFAERS: 1US FAERS
82CellulitisFAERS: 1US FAERS
83Chemical burns of eyeFAERS: 1US FAERS
84Chemical eye injuryFAERS: 1US FAERS
85ColectomyFAERS: 1US FAERS
86Contraindicated product administeredFAERS: 1US FAERS
87Corneal epithelium defectFAERS: 1US FAERS
88Corneal exfoliationFAERS: 1US FAERS
89Culture wound positiveFAERS: 1US FAERS
90Device connection issueFAERS: 1US FAERS
91Device use errorFAERS: 1US FAERS
92Eye inflammationFAERS: 1US FAERS
93Eyelid painFAERS: 1US FAERS
94FatigueFAERS: 1US FAERS
95Feeling abnormalFAERS: 1US FAERS
96FolliculitisFAERS: 1US FAERS
97General physical condition abnormalFAERS: 1US FAERS
98HypotensionFAERS: 1US FAERS
99Implant site pustulesFAERS: 1US FAERS
100Incision site complicationFAERS: 1US FAERS
101Incision site erythemaFAERS: 1US FAERS
102Incision site infectionFAERS: 1US FAERS
103InfectionFAERS: 1US FAERS
104Infusion site inflammationFAERS: 1US FAERS
105Liquid product physical issueFAERS: 1US FAERS
106MalaiseFAERS: 1US FAERS
107Manufacturing production issueFAERS: 1US FAERS
108Medical device complicationFAERS: 1US FAERS
109NauseaFAERS: 1US FAERS
110Open woundFAERS: 1US FAERS
111Oropharyngeal painFAERS: 1US FAERS
112PainFAERS: 1US FAERS
113PalpitationsFAERS: 1US FAERS
114PhlebitisFAERS: 1US FAERS
115Preoperative CareFAERS: 1US FAERS
116Procedural site reactionFAERS: 1US FAERS
117Product caught fireFAERS: 1US FAERS
118Product label confusionFAERS: 1US FAERS
119Product packaging issueFAERS: 1US FAERS
120Reaction to azo-dyesFAERS: 1US FAERS
121Reaction to drug excipientsFAERS: 1US FAERS
122Skin lesionFAERS: 1US FAERS
123StridorFAERS: 1US FAERS
124Superinfection bacterialFAERS: 1US FAERS
125SyncopeFAERS: 1US FAERS
126WheezingFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.